- Thinly traded micro cap Enochian Biosciences (OTCQB:ENOB +19.2%) is up on more than double normal volume, albeit on turnover of only 90K shares, ahead of today's investor event.
- The company's pipeline includes preventative and therapeutic HIV vaccines and dendritic cell vaccines for cancer.
- On the working capital front, at the end of September, it had $13.4M in cash while operations consumed $1.8M during the quarter.
Enochian Bio up 19% on investor update
Recommended For You
About RENB Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
RENB | - | - |
Renovaro Inc. |